Clinical Trial Update: Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update notes the completion of a biological therapy study in children with refractory or recurrent neuroblastoma or other tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Neuroblastoma
• Sarcoma

Snippet

Sponsor: Children's Oncology Group | Conditions: Melanoma (Skin), Neuroblastoma | Phase 1 | Status: COMPLETED